Andere Sprachen Atreca, Inc.

Aktien

A2PLNM

US04965G1094

BCEL

Markt geschlossen - OTC Markets Andere Börsenplätze 21:34:26 26.04.2024			% 5 Tage	% 1. Jan.
0,08 ^USD	-6,43 %		+3,90 %	-39,39 %

06.02.	Atreca, Inc. kündigt Rücktritt des Vorstands an	CI
2023	Immunome unterzeichnet Kaufvertrag für den Erwerb von Antikörper-bezogenen Vermögenswerten von Atreca	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCX	18.04.
North American Morning Briefing : Stock Futures -2-	17.04.
North American Morning Briefing : Traders Await -2-	10.04.
Atreca, Inc.(OTCPK:BCEL) dropped from S&P TMI Index	21.03.
Atreca, Inc.(OTCPK:BCEL) dropped from NASDAQ Composite Index	18.03.
Atreca : Failure to Satisfy Listing Rule - Form 8-K	11.03.
Atreca, Inc. Announces Board Resignations	06.02.
BCEL Stock Alert: Halper Sadeh LLC Is Investigating Atreca, Inc.	26.12.
Immunome Signs Asset Purchase Agreement for Acquisition of Antibody-Related Assets From Atreca	26.12.
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome	26.12.
Immunome, Inc. entered into an agreement to acquire Substantially all Assets of Atreca, Inc. for $12.5 million.	26.12.
Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives	14.11.
Atreca, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Atreca, Inc. to Continue Exploring Strategic Alternatives	14.11.
Investors Remain Cautious Over Fed Moves, Setting Wall Street Up for Lower Open	20.10.23
Top Premarket Gainers	19.10.23
Intelligent Bio Solutions Inc. (NASDAQ: INBS): "Fingerprint Sweat Analysis: Revolutionizing Drug Screening with Speed and Precision" (JAGX, BCEL, CDIO)	13.10.23
Atreca to Terminate Lease on California Headquarters; Chief Financial Officer Resigns	21.09.23
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross	21.09.23
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross	21.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Atreca, Inc.

Aktien

A2PLNM

US04965G1094

BCEL

Andere Sprachen

Filter